Pregabalin Pfizer

Country: Kesatuan Eropah

Bahasa: Inggeris

Sumber: EMA (European Medicines Agency)

Beli sekarang

Risalah maklumat Risalah maklumat (PIL)
12-01-2024
Ciri produk Ciri produk (SPC)
12-01-2024
Laporan Penilaian Awam Laporan Penilaian Awam (PAR)
07-05-2014

Bahan aktif:

pregabalin

Boleh didapati daripada:

Upjohn EESV

Kod ATC:

N03AX16

INN (Nama Antarabangsa):

pregabalin

Kumpulan terapeutik:

Antiepileptics,

Kawasan terapeutik:

Anxiety Disorders; Epilepsy

Tanda-tanda terapeutik:

Neuropathic painPregabalin Pfizer is indicated for the treatment of peripheral and central neuropathic pain in adults.EpilepsyPregabalin Pfizer is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.Generalised Anxiety DisorderPregabalin Pfizer is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.

Ringkasan produk:

Revision: 29

Status kebenaran:

Authorised

Tarikh kebenaran:

2014-04-10

Risalah maklumat

                                56
B. PACKAGE LEAFLET
57
PACKAGE LEAFLET: INFORMATION FOR THE USER
PREGABALIN PFIZER 25 MG HARD CAPSULES,
PREGABALIN PFIZER 50 MG HARD CAPSULES,
PREGABALIN PFIZER 75 MG HARD CAPSULES,
PREGABALIN PFIZER 100 MG HARD CAPSULES,
PREGABALIN PFIZER 150 MG HARD CAPSULES,
PREGABALIN PFIZER 200 MG HARD CAPSULES,
PREGABALIN PFIZER 225 MG HARD CAPSULES,
PREGABALIN PFIZER 300 MG HARD CAPSULES
pregabalin
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU
.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Pregabalin Pfizer is and what it is used for
2.
What you need to know before you take Pregabalin Pfizer
3.
How to take Pregabalin Pfizer
4.
Possible side effects
5.
How to store Pregabalin Pfizer
6.
Contents of the pack and other information
1.
WHAT PREGABALIN PFIZER IS AND WHAT IT IS USED FOR
Pregabalin Pfizer belongs to a group of medicines used to treat
epilepsy, neuropathic pain and
Generalised Anxiety Disorder (GAD) in adults.
PERIPHERAL AND CENTRAL NEUROPATHIC PAIN:
Pregabalin Pfizer is used to treat long lasting pain caused
by damage to the nerves. A variety of diseases can cause peripheral
neuropathic pain, such as diabetes
or shingles. Pain sensations may be described as hot, burning,
throbbing, shooting, stabbing, sharp,
cramping, aching, tingling, numbness, pins and needles. Peripheral and
central neuropathic pain may
also be associated with mood changes, sleep disturbance, fatigue
(tiredness), and can have an impact
on physical and social functioning and overall quality of life.
EPILEPSY:
Pregabalin Pfizer is used to treat a certain form of epilepsy
                                
                                Baca dokumen lengkap
                                
                            

Ciri produk

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Pregabalin Pfizer 25 mg hard capsules
Pregabalin Pfizer 50 mg hard capsules
Pregabalin Pfizer 75 mg hard capsules
Pregabalin Pfizer 100 mg hard capsules
Pregabalin Pfizer 150 mg hard capsules
Pregabalin Pfizer 200 mg hard capsules
Pregabalin Pfizer 225 mg hard capsules
Pregabalin Pfizer 300 mg hard capsules
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Pregabalin Pfizer 25 mg hard capsules
Each hard capsule contains 25 mg of pregabalin.
Pregabalin Pfizer 50 mg hard capsules
Each hard capsule contains 50 mg of pregabalin.
Pregabalin Pfizer 75 mg hard capsules
Each hard capsule contains 75 mg of pregabalin.
_ _
Pregabalin Pfizer 100 mg hard capsules
Each hard capsule contains 100 mg of pregabalin.
Pregabalin Pfizer 150 mg hard capsules
Each hard capsule contains 150 mg of pregabalin.
_ _
Pregabalin Pfizer 200 mg hard capsules
Each hard capsule contains 200 mg of pregabalin.
_ _
Pregabalin Pfizer 225 mg hard capsules
Each hard capsule contains 225 mg of pregabalin.
Pregabalin Pfizer 300 mg hard capsules
Each hard capsule contains 300 mg of pregabalin.
_ _
Excipients with known effect
Pregabalin Pfizer 25 mg hard capsules
Each hard capsule also contains 35 mg lactose monohydrate.
Pregabalin Pfizer 50 mg hard capsules
Each hard capsule also contains 70 mg lactose monohydrate.
Pregabalin Pfizer 75 mg hard capsules
Each hard capsule also contains 8.25 mg lactose monohydrate.
Pregabalin Pfizer 100 mg hard capsules
Each hard capsule also contains 11 mg lactose monohydrate.
Pregabalin Pfizer 150 mg hard capsules
Each hard capsule also contains 16.50 mg lactose monohydrate.
Pregabalin Pfizer 200 mg hard capsules
Each hard capsule also contains 22 mg lactose monohydrate.
3
Pregabalin Pfizer 225 mg hard capsules
Each hard capsule also contains 24.75 mg lactose monohydrate.
Pregabalin Pfizer 300 mg hard capsules
Each hard capsule also contains 33 mg lactose monohydrate.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Hard cap
                                
                                Baca dokumen lengkap
                                
                            

Dokumen dalam bahasa lain

Risalah maklumat Risalah maklumat Bulgaria 12-01-2024
Ciri produk Ciri produk Bulgaria 12-01-2024
Laporan Penilaian Awam Laporan Penilaian Awam Bulgaria 07-05-2014
Risalah maklumat Risalah maklumat Sepanyol 12-01-2024
Ciri produk Ciri produk Sepanyol 12-01-2024
Laporan Penilaian Awam Laporan Penilaian Awam Sepanyol 07-05-2014
Risalah maklumat Risalah maklumat Czech 12-01-2024
Ciri produk Ciri produk Czech 12-01-2024
Laporan Penilaian Awam Laporan Penilaian Awam Czech 07-05-2014
Risalah maklumat Risalah maklumat Denmark 12-01-2024
Ciri produk Ciri produk Denmark 12-01-2024
Laporan Penilaian Awam Laporan Penilaian Awam Denmark 07-05-2014
Risalah maklumat Risalah maklumat Jerman 12-01-2024
Ciri produk Ciri produk Jerman 12-01-2024
Laporan Penilaian Awam Laporan Penilaian Awam Jerman 07-05-2014
Risalah maklumat Risalah maklumat Estonia 12-01-2024
Ciri produk Ciri produk Estonia 12-01-2024
Laporan Penilaian Awam Laporan Penilaian Awam Estonia 07-05-2014
Risalah maklumat Risalah maklumat Greek 12-01-2024
Ciri produk Ciri produk Greek 12-01-2024
Laporan Penilaian Awam Laporan Penilaian Awam Greek 07-05-2014
Risalah maklumat Risalah maklumat Perancis 12-01-2024
Ciri produk Ciri produk Perancis 12-01-2024
Laporan Penilaian Awam Laporan Penilaian Awam Perancis 07-05-2014
Risalah maklumat Risalah maklumat Itali 12-01-2024
Ciri produk Ciri produk Itali 12-01-2024
Laporan Penilaian Awam Laporan Penilaian Awam Itali 07-05-2014
Risalah maklumat Risalah maklumat Latvia 12-01-2024
Ciri produk Ciri produk Latvia 12-01-2024
Laporan Penilaian Awam Laporan Penilaian Awam Latvia 07-05-2014
Risalah maklumat Risalah maklumat Lithuania 12-01-2024
Ciri produk Ciri produk Lithuania 12-01-2024
Laporan Penilaian Awam Laporan Penilaian Awam Lithuania 07-05-2014
Risalah maklumat Risalah maklumat Hungary 12-01-2024
Ciri produk Ciri produk Hungary 12-01-2024
Laporan Penilaian Awam Laporan Penilaian Awam Hungary 07-05-2014
Risalah maklumat Risalah maklumat Malta 12-01-2024
Ciri produk Ciri produk Malta 12-01-2024
Laporan Penilaian Awam Laporan Penilaian Awam Malta 07-05-2014
Risalah maklumat Risalah maklumat Belanda 12-01-2024
Ciri produk Ciri produk Belanda 12-01-2024
Laporan Penilaian Awam Laporan Penilaian Awam Belanda 07-05-2014
Risalah maklumat Risalah maklumat Poland 12-01-2024
Ciri produk Ciri produk Poland 12-01-2024
Laporan Penilaian Awam Laporan Penilaian Awam Poland 07-05-2014
Risalah maklumat Risalah maklumat Portugis 12-01-2024
Ciri produk Ciri produk Portugis 12-01-2024
Laporan Penilaian Awam Laporan Penilaian Awam Portugis 07-05-2014
Risalah maklumat Risalah maklumat Romania 12-01-2024
Ciri produk Ciri produk Romania 12-01-2024
Laporan Penilaian Awam Laporan Penilaian Awam Romania 07-05-2014
Risalah maklumat Risalah maklumat Slovak 12-01-2024
Ciri produk Ciri produk Slovak 12-01-2024
Laporan Penilaian Awam Laporan Penilaian Awam Slovak 07-05-2014
Risalah maklumat Risalah maklumat Slovenia 12-01-2024
Ciri produk Ciri produk Slovenia 12-01-2024
Laporan Penilaian Awam Laporan Penilaian Awam Slovenia 07-05-2014
Risalah maklumat Risalah maklumat Finland 12-01-2024
Ciri produk Ciri produk Finland 12-01-2024
Laporan Penilaian Awam Laporan Penilaian Awam Finland 07-05-2014
Risalah maklumat Risalah maklumat Sweden 12-01-2024
Ciri produk Ciri produk Sweden 12-01-2024
Laporan Penilaian Awam Laporan Penilaian Awam Sweden 07-05-2014
Risalah maklumat Risalah maklumat Norway 12-01-2024
Ciri produk Ciri produk Norway 12-01-2024
Risalah maklumat Risalah maklumat Iceland 12-01-2024
Ciri produk Ciri produk Iceland 12-01-2024
Risalah maklumat Risalah maklumat Croat 12-01-2024
Ciri produk Ciri produk Croat 12-01-2024
Laporan Penilaian Awam Laporan Penilaian Awam Croat 07-05-2014

Cari amaran yang berkaitan dengan produk ini